Gastric cancer chemoprevention: the current evidence - PubMed (original) (raw)
Review
. 2013 Jun;42(2):299-316.
doi: 10.1016/j.gtc.2013.02.001. Epub 2013 Mar 13.
Affiliations
- PMID: 23639642
- DOI: 10.1016/j.gtc.2013.02.001
Review
Gastric cancer chemoprevention: the current evidence
Victoria P Y Tan et al. Gastroenterol Clin North Am. 2013 Jun.
Abstract
Chemoprevention may form the cornerstone in the management of gastric adenocarcinoma of the future. Helicobacter pylori eradication and aspirin and/or nonsteroidal anti-inflammatory drug therapy have emerged as front-runner chemotherapeutic agents due to the putative pathogenic mechanisms that they address. Before a population-based chemopreventive strategy can be recommended on a large scale, randomized controlled trials with follow-up of more than 10 years of these 2 agents in populations at high gastric adenocarcinoma risk is urgently awaited.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
- Chemoprevention for gastric cancer.
Ford AC. Ford AC. Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):581-92. doi: 10.1016/j.bpg.2011.09.002. Best Pract Res Clin Gastroenterol. 2011. PMID: 22122773 Review. - [The association between Helicobacter pylori and gastric cancer: the role of infection's eradication. Recent advances].
Eusebi LH, Ceroni L, Laterza L, Kurelac I, Fuccio L. Eusebi LH, et al. Recenti Prog Med. 2010 Feb;101(2):66-9. Recenti Prog Med. 2010. PMID: 20433004 Review. Italian. - Helicobacter pylori eradication for the prevention of gastric cancer.
Kuipers EJ, Sipponen P. Kuipers EJ, et al. Helicobacter. 2006 Oct;11 Suppl 1:52-7. doi: 10.1111/j.1478-405X.2006.00425.x. Helicobacter. 2006. PMID: 16925613 Review. - [A case for proton pump blocker... When cough comes from the stomach].
Wepner U. Wepner U. MMW Fortschr Med. 2002 Nov 7;144(45):10-2. MMW Fortschr Med. 2002. PMID: 12534054 German. No abstract available. - Future candidates for indications of Helicobacter pylori eradication: do the indications need to be revised?
Lee SY. Lee SY. J Gastroenterol Hepatol. 2012 Feb;27(2):200-11. doi: 10.1111/j.1440-1746.2011.06961.x. J Gastroenterol Hepatol. 2012. PMID: 22098099 Review.
Cited by
- Suppressed Helicobacter pylori-associated gastric tumorigenesis in Fat-1 transgenic mice producing endogenous ω-3 polyunsaturated fatty acids.
Han YM, Kim KJ, Jeong M, Park JM, Go EJ, Kang JX, Hong SP, Hahm KB. Han YM, et al. Oncotarget. 2016 Oct 11;7(41):66606-66622. doi: 10.18632/oncotarget.11261. Oncotarget. 2016. PMID: 27528223 Free PMC article. - Different Pathophysiology of Gastritis in East and West? A Western Perspective.
Wirth HP, Yang M. Wirth HP, et al. Inflamm Intest Dis. 2016 Oct;1(3):113-122. doi: 10.1159/000446300. Epub 2016 May 14. Inflamm Intest Dis. 2016. PMID: 29922666 Free PMC article. Review. - Helicobacter pylori in gastric carcinogenesis.
Ahn HJ, Lee DS. Ahn HJ, et al. World J Gastrointest Oncol. 2015 Dec 15;7(12):455-65. doi: 10.4251/wjgo.v7.i12.455. World J Gastrointest Oncol. 2015. PMID: 26690981 Free PMC article. Review. - Gastric cáncer: Overview.
Piazuelo MB, Correa P. Piazuelo MB, et al. Colomb Med (Cali). 2013 Sep 30;44(3):192-201. eCollection 2013 Jul. Colomb Med (Cali). 2013. PMID: 24892619 Free PMC article. Review. - Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients.
Zhang G, Qu Y, Dang S, Yang Q, Shi B, Hou P. Zhang G, et al. Diagn Pathol. 2013 Oct 21;8:173. doi: 10.1186/1746-1596-8-173. Diagn Pathol. 2013. PMID: 24144008 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical